Back to search results

Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

Abroad (travel likely)RecruitingPHASE2

Conditions

Non-cystic Fibrosis Bronchiectasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • The Prince Charles Hospital, Queensland, Australia

  • Westmead Hospital, Westmead, Australia

  • Fukuoka University Chikushi Hopsital, Chikushino-shi, Japan

  • Kyusho Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan

  • Ibaraki Prefectural Central Hospital, Ibaraki, Japan

  • Kazunori Tobino Iizuka Hospital, Iizuka-shi, Japan

  • National Hospital Organization Minami Kyoto Hospital, Kyoto, Japan

  • Matsusaka Municipal Hospital, Mie, Japan

  • National Hospital Organization Kinki Chuo Chest Medical Center, Osaka, Japan

  • Shimonoseki City Hospital, Shimonoseki-shi, Japan

  • Japan Anti-Tuberculosis Association, Fukujuji Hospital, Tokyo, Japan

  • Keio University Hospital, Tokyo, Japan

  • National Hospital Organization Mie Chuo Medical Center, Tsu, Japan

Study leads

  • Study Director

    CSL Behring

View source on ClinicalTrials.gov(opens in a new tab)